Table 2.
Clinical characteristics of newly registered PLHIV from January 2017 to June 2018 at ART centers in two selected districts of Karnataka, India
| Characteristics | N | (%) |
|---|---|---|
| Total | 4020 | (100) |
| Body Mass Index (kg/m2) | ||
| Underweight (<18.5) | 1731 | (43.1) |
| Normal (18.5–22.99) | 1530 | (38.0) |
| Overweight (23.0–24.99) | 349 | (8.7) |
| Obese (≥25.0) | 366 | (9.1) |
| Not recorded | 44 | (1.1) |
| CD4 cell count (cells/mm3) | ||
| Less than 200 | 1278 | (31.8) |
| 200–349 | 788 | (19.6) |
| 350–500 | 747 | (18.6) |
| More than 500 | 1137 | (28.3) |
| Not recorded | 70 | (1.7) |
| WHO Clinical Staginga | ||
| Stage I | 1814 | (45.1) |
| Stage II | 1773 | (44.1) |
| Stage III | 374 | (9.4) |
| Stage IV | 50 | (1.2) |
| Not recorded | 9 | (0.2) |
| Functional statusa | ||
| Working | 3600 | (89.6) |
| Ambulatory | 243 | (6.0) |
| Bedridden | 173 | (4.3) |
| Not recorded | 4 | (0.1) |
| ART regimen | ||
| TLE regimen | 3401 | (84.6) |
| Others | 268 | (6.7) |
| Not recorded | 351 | (8.7) |
| Anemia statusb | ||
| No anemia | 615 | (15.3) |
| Mild | 833 | (20.7) |
| Moderate | 2050 | (51.0) |
| Severe | 264 | (6.6) |
| Not recorded | 258 | (6.4) |
| Alcohol use | ||
| Ever user | 538 | (13.3) |
| Never user | 1594 | (39.7) |
| Not recorded | 1888 | (47.0) |
| Smoking status | ||
| Ever user | 309 | (7.7) |
| Never user | 1703 | (42.4) |
| Not recorded | 2008 | (49.9) |
| Tobacco chewing status | ||
| Ever user | 465 | (11.6) |
| Never user | 1559 | (38.8) |
| Not recorded | 1996 | (49.6) |
| Entry pointa | ||
| VCT (Direct walk in) | 1962 | (48.8) |
| Out/in-patient | 1195 | (29.7) |
| Private practitioner | 524 | (13.0) |
| Others | 225 | (5.6) |
| Not recorded | 114 | (2.9) |
| ART statusa | ||
| Alive on ART | 3018 | (75.1) |
| Died | 466 | (11.6) |
| Lost to follow-up | 186 | (4.6) |
| Transfer out | 108 | (2.7) |
| Opted out | 230 | (5.7) |
| Stopped (on medical advice) | 12 | (0.3) |
aAs categorized and recorded in the ART register.
bWHO classification for Asian population.
Abbreviations: ART, antiretroviral therapy; CD4, cluster of differentiation 4; PLHIV, people living with HIV; VCT, voluntary counselling and testing; TLE, tenofovir lamivudine efavirenz; WHO, World Health Organization.